Grade Post Therapy Clin (yc) (NET Colon and Rectum (V9 2024+))
Data Item Details
Parent Schema: NET Colon and Rectum (V9 2024+)
NAACCR Item: #1068
NAACCR XML ID: gradePostTherapyClin
Organization Field Mapping
Organization | Field Name | ID# | ID Name | Required |
|---|---|---|---|---|
KCR | Grade Post Therapy Clin (yc) | 30141 | GradePostTherapyClin | yes |
SEER | Grade Post Therapy Clin (yc) | gradePostTherapyClin | yes |
Valid Values
Notes
Note 1 Leave Grade Post Therapy Clin (yc) blank when
No neoadjuvant therapy
Clinical or pathological case only
Neoadjuvant therapy completed, no microscopic exam is done prior to surgery/resection of primary tumor
There is only one grade available and it cannot be determined if it is clinical, pathological, post therapy clinical or post therapy pathological
Note 2 Assign the highest grade from the microscopically sampled specimen of the primary site following neoadjuvant therapy or primary systemic/radiation therapy.
Note 3 If there are multiple tumors with different grades abstracted as one primary, code the highest grade.
Note 4 Codes 1-3 take priority over codes A-D.
Grades A-D should only be used in the absence of a physician's statement of grade (G1, G2, G3) or no results for Ki-67 or Mitotic Count (See also Note 6)
Note 5 Do not code grade based on the following terminology
Neuroendocrine carcinoma, low grade (8240/3)
Neuroendocrine carcinoma, well differentiated (8240/3)
Neuroendocrine carcinoma, moderately differentiated (8249/3)
Poorly differentiated neuroendocrine carcinoma (8246/3)
Note 6 Code grade based on the physician's documentation (G1, G2, G3) OR in the absence of a physician's statement, code grade based on the Ki-67 and Mitotic Count.
If a Ki-67 is documented as less than 3, many times the mitotic count is not done. In this situation, the Ki-67 alone is enough to code the grade (G1).
Grades 2 and 3, are either/or for Ki-67 and Mitotic Count. You do not need both the Ki-67 and Mitotic Count to assign grade 2 or 3.
Note 7 Code 9 (unknown) when
Microscopic exam is done after neoadjuvant therapy and grade from the primary site is not documented
Microscopic exam is done after neoadjuvant therapy and there is no residual cancer
Grade checked “not applicable” on CAP Protocol (if available) and no other grade information is available
Code | Description |
|---|---|
1 | G1: Mitotic count (per 2mm2) less than 2 AND |
Stated as WHO Grade 1 |
2 | G2: Mitotic count (per 2mm2) equal 2-20 OR |
Stated as WHO Grade 2 |
3 | G3: Mitotic count (per 2mm2) greater than 20 OR |
Stated as WHO Grade 3 |
A | Well differentiated |
B | Moderately differentiated |
C | Poorly differentiated |
D | Undifferentiated, anaplastic |
9 | Grade cannot be assessed (GX); Unknown |
<BLANK> | See Note 1 |
For official definitions and additional context, refer to the NAACCR Data Dictionary.